Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about China Pharma Billionaires' Hepalink Invests $60M In TPG Fund
Family Office

China Pharma Billionaires' Hepalink Invests $60M In TPG Fund

by forbes.com posted 2years ago 9534 views
<span style="line-height: 20.8px;">Shenzhen Hepalink Pharmaceutical, the Shenzhen-listed main business of China billionaire couple Li Li and Li Tan, will invest $60 million in TPG Biotechnology Partners V, which mainly targets biomedical technology and life science companies, Hepalink said today.</span>